Cubist Systematic Strategies’s Relay Therapeutics RLAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-317,211
| Closed | -$1.31M | – | 2148 |
|
|
2024
Q4 | $1.31M | Sell |
317,211
-42,121
| -12% | -$174K | 0.01% | 736 |
|
|
2024
Q3 | $2.54M | Buy |
+359,332
| New | +$2.54M | 0.02% | 569 |
|
|
2024
Q2 | – | Sell |
-1,229
| Closed | -$10.2K | – | 2410 |
|
|
2024
Q1 | $10.2K | Buy |
+1,229
| New | +$10.2K | ﹤0.01% | 2037 |
|
|
2023
Q4 | – | Sell |
-279,115
| Closed | -$2.35M | – | 2576 |
|
|
2023
Q3 | $2.35M | Buy |
279,115
+101,612
| +57% | +$855K | 0.02% | 722 |
|
|
2023
Q2 | $2.23M | Buy |
+177,503
| New | +$2.23M | 0.01% | 839 |
|
|
2023
Q1 | – | Sell |
-62,560
| Closed | -$935K | – | 3200 |
|
|
2022
Q4 | $935K | Buy |
62,560
+10,626
| +20% | +$159K | 0.01% | 1803 |
|
|
2022
Q3 | $1.16M | Sell |
51,934
-7,286
| -12% | -$163K | 0.01% | 1963 |
|
|
2022
Q2 | $992K | Buy |
59,220
+41,922
| +242% | +$702K | 0.01% | 2126 |
|
|
2022
Q1 | $518K | Buy |
17,298
+9,653
| +126% | +$289K | ﹤0.01% | 2495 |
|
|
2021
Q4 | $235K | Sell |
7,645
-58,673
| -88% | -$1.8M | ﹤0.01% | 2947 |
|
|
2021
Q3 | $2.09M | Buy |
66,318
+38,385
| +137% | +$1.21M | 0.03% | 981 |
|
|
2021
Q2 | $1.02M | Sell |
27,933
-854
| -3% | -$31.2K | 0.01% | 1561 |
|
|
2021
Q1 | $995K | Buy |
28,787
+12,387
| +76% | +$428K | 0.01% | 1539 |
|
|
2020
Q4 | $682K | Buy |
16,400
+1,881
| +13% | +$78.2K | 0.01% | 1606 |
|
|
2020
Q3 | $618K | Buy |
+14,519
| New | +$618K | 0.01% | 1614 |
|